Skip to main content
DIRUI INDUSTRIAL CO.,LTD. logo

DIRUI INDUSTRIAL CO.,LTD. — Investor Relations & Filings

Ticker · 300396 ISIN · CNE100001XS7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,690 across all filing types
Latest filing 2016-04-08 Report Publication Anno…
Country CN China
Listing Shenzhen Stock Exchange 300396

About DIRUI INDUSTRIAL CO.,LTD.

https://www.dirui.com.cn

DIRUI INDUSTRIAL CO.,LTD. specializes in the research, development, manufacturing, and distribution of medical laboratory instruments and diagnostic reagents. The company provides comprehensive solutions for in-vitro diagnostics (IVD), focusing on several key clinical areas including urinalysis, biochemistry, hematology, and chemiluminescence immunoassay. Its product portfolio features high-throughput automated analyzers and integrated laboratory systems designed to enhance diagnostic efficiency and accuracy. DIRUI serves a global market, providing medical institutions and laboratories with a wide range of diagnostic tools, from urine sediment analysis to vaginal secretion testing. The company emphasizes technological innovation and quality control to support clinical decision-making and patient care through reliable laboratory automation and standardized testing protocols.

Recent filings

Filing Released Lang Actions
2015年年度报告披露提示性公告
Report Publication Announcement Classification · 100% confidence The document is a short announcement (321 characters) from the company about the disclosure of its 2015 Annual Report. It states that the full annual report and summary were published on April 9, 2016, on the designated disclosure website. The document itself does not contain the annual report but is notifying investors of its availability. According to the 'Menu vs Meal' rule, such a short notice announcing the publication of a report should be classified as a Report Publication Announcement (RPA), not as the Annual Report (10-K).
2016-04-08 Chinese
第二届监事会第十四次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Changchun Dirui Medical Technology Co., Ltd. It details the approval of various reports related to the 2015 fiscal year, including the Supervisory Board Work Report, the 2015 Annual Report and its summary, the 2015 Financial Final Report, the 2015 Profit Distribution Plan, the 2015 Fundraising Usage Report, the 2015 Internal Control Self-Evaluation Report, and the proposal to reappoint the audit firm for 2016. The document repeatedly states that the detailed reports are available on an external website (cninfo.com.cn) and that these resolutions will be submitted to the 2015 Annual General Meeting for approval. The document itself does not contain the full reports or substantive financial data but is a formal announcement of the Supervisory Board's resolutions regarding these reports. The document length is short (2241 characters) and it serves as a meeting resolution announcement rather than the reports themselves. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for announcements and resolutions that do not contain the full report or detailed financial data.
2016-04-08 Chinese
国信证券股份有限公司关于公司首次公开发行股票2015年度跟踪报告
Regulatory Filings Classification · 90% confidence The document is titled as a "2015年度跟踪报告" (2015 Annual Tracking Report) related to the initial public offering (IPO) of Changchun Dirui Medical Technology Co., Ltd., prepared by Guosen Securities Co., Ltd. It details the sponsor's work overview, supervision of fundraising, company governance, and compliance with commitments during the year 2015. The content includes detailed descriptions of the sponsor's review and supervision activities, internal controls, and compliance, which are typical of a tracking report following an IPO. The document is 2435 characters long, which is relatively short but contains substantive content about the sponsor's monitoring activities rather than just an announcement or certification. This type of report is not a full annual report (10-K), nor an audit report, nor a regulatory filing or announcement. It is a specific type of report related to IPO follow-up and sponsor supervision, which aligns best with the category of Regulatory Filings (RNS) as a fallback for miscellaneous regulatory reports that do not fit other categories. There is no indication that this is an Annual Report, Earnings Release, or other specific category. Therefore, the best classification is Regulatory Filings (RNS).
2016-04-08 Chinese
关于重大资产重组购买资产2015年度业绩承诺实现情况的专项审核报告
Audit Report / Information Classification · 95% confidence The document is a specialized audit report concerning the performance commitment realization for a major asset restructuring purchase in the fiscal year 2015. It includes an audit opinion from a certified public accounting firm, references to regulatory requirements (China Securities Regulatory Commission Order No. 109), and detailed financial data verifying the achievement of profit commitments. The document is titled as a '专项审核报告' (special audit report) and contains audit findings and conclusions, not just an announcement or summary. The length is 2408 characters, which is relatively short but the content is substantive and includes audit results and financial figures. This fits the definition of an Audit Report / Information (AR) rather than a full Annual Report or a simple announcement. Therefore, the correct classification is AR with high confidence. FY 2015
2016-04-08 Chinese
关于公司非经营性资金占用及其他关联资金往来情况汇总表的专项审核报告
Audit Report / Information Classification · 95% confidence The document is titled as a "专项审核报告" (Special Audit Report) concerning non-operating fund occupation and other related party fund transactions for the year 2015 of Changchun Dirui Medical Technology Co., Ltd. It includes an audit opinion by a registered accounting firm and detailed tables summarizing related party transactions. The document references compliance with Chinese securities regulatory requirements and audit standards. It is a standalone audit report focusing on a specific aspect of the company's financials (related party fund transactions), not a full annual report or interim report. The length is about 2,421 characters, which is consistent with a detailed audit report but not a brief announcement. Therefore, it fits best under the category of Audit Report / Information (AR). FY 2015
2016-04-08 Chinese
关于限售股份解禁上市流通的提示性公告
Share Issue/Capital Change Classification · 95% confidence The document is a public announcement regarding the lifting of restrictions on certain shares (limited shares) and their subsequent listing for trading. It details the number of shares becoming tradable, the shareholders involved, their commitments, and the regulatory compliance and verification by the sponsoring institution. The document does not contain financial statements or detailed financial performance data but is an official notice about share circulation changes. This fits the category of Share Issue/Capital Change announcements, specifically about restricted shares becoming freely tradable. The document length is short (2582 characters), and it is not a report or financial statement but an announcement of a capital-related event.
2016-04-05 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.